A detailed history of Apeiron Ria LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Apeiron Ria LLC holds 2,341 shares of MRK stock, worth $232,625. This represents 0.08% of its overall portfolio holdings.

Number of Shares
2,341
Previous 2,371 1.27%
Holding current value
$232,625
Previous $293,000 9.56%
% of portfolio
0.08%
Previous 0.09%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$111.15 - $128.97 $3,334 - $3,869
-30 Reduced 1.27%
2,341 $265,000
Q2 2024

Jul 16, 2024

SELL
$123.8 - $132.96 $3,837 - $4,121
-31 Reduced 1.29%
2,371 $293,000
Q1 2024

Apr 15, 2024

BUY
$113.24 - $131.95 $12,796 - $14,910
113 Added 4.94%
2,402 $316,000
Q4 2023

Jan 12, 2024

BUY
$100.18 - $109.02 $229,312 - $249,546
2,289 New
2,289 $249,000
Q2 2022

Jul 26, 2022

BUY
$83.49 - $94.64 $19,870 - $22,524
238 New
238 $217,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $252B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Apeiron Ria LLC Portfolio

Follow Apeiron Ria LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Apeiron Ria LLC, based on Form 13F filings with the SEC.

News

Stay updated on Apeiron Ria LLC with notifications on news.